CDKN2A and urinary bladder carcinoma: In summary, using a series of bioinformatics and retrospective analyses, the present study identified a subset of seven genes (CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9), which were significantly associated with progression and prognosis of bladder cancer.